Top

Published in:

01-03-2020 | Stroke | IM - COMMENTARY

Female sex and stroke in atrial fibrillation: an intriguing relationship

Authors: Giuseppe Boriani, Jacopo Colella, Jacopo Imberti, Elisa Fantecchi, Marco Vitolo

Published in: Internal and Emergency Medicine | Issue 2/2020

Excerpt

The growing epidemics of atrial fibrillation (AF) as well as the possibility to prevent stroke by use of anticoagulants in patients with a profile at risk of thromboembolism promoted in the last 20 years the elaboration and the refinement of scores for better characterising the risk of stroke, as a guide for anticoagulants prescription [1, 2]. …

Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A (2006) The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J 27:893–894CrossRef

Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B et al (2018) Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest 154:1121–1201CrossRef

Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870CrossRef

Eckman MH, Singer DE, Rosand J, Greenberg SM (2011) Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 4:14–21CrossRef

Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE (2016) Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 13:321–332CrossRef

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128(509–518):e502

Lip GY, Laroche C, Boriani G, Cimaglia P, Dan GA, Santini M et al (2015) Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace 17:24–31CrossRef

Malavasi VL, Pettorelli D, Fantecchi E, Zoccali C, Laronga G, Trenti T et al (2018) Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function: post hoc analysis of a prospective cohort. Intern Emerg Med 13:1059–1067CrossRef

Boriani G, Laroche C, Diemberger I, Fantecchi E, Meeder J, Kurpesa M et al (2018) Overweight and obesity in patients with atrial fibrillation: sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. J Cardiovasc Electrophysiol 29:566–572CrossRef

10.

Camm AJ, Savelieva I (2017) Female gender as a risk factor for stroke associated with atrial fibrillation. Eur Heart J 38(19):1480–1484CrossRef

11.

Marzona I, Proietti M, Vannini T, Tettamanti M, Nobili A, Medaglia M et al (2019) Sex-related differences in prevalence, treatment and outcomes in patients with atrial fibrillation. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02134-z CrossRefPubMed

12.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG et al (2005) Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112:1687–1691CrossRef

13.

Oza NM, Baveja S, Tedrow U (2015) Bridging the gender gap in atrial fibrillation. Expert Rev Cardiovasc Ther 13:317–323CrossRef

14.

Boriani G, Lip GYH, Ricci RP, Proclemer A, Landolina M, Lunati M et al (2017) The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden. Europace 19:1767–1775CrossRef

15.

Anselmino M, Battaglia A, Gallo C, Gili S, Matta M, Castagno D et al (2015) Atrial fibrillation and female sex. J Cardiovasc Med (Hagerstown) 16:795–801CrossRef

16.

Penttilä T, Lehto M, Niiranen J, Mehtälä J, Khanfir H, Lassila R et al (2019) Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy. Eur Heart J Cardiovasc Pharmacother 5:29–36CrossRef

17.

Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P et al (2006) Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 27:1947–1953CrossRef

18.

Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M et al (2001) New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103:2365–2370CrossRef

19.

Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M et al (2016) Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 532:h7013CrossRef

20.

Marzona I, Proietti M, Farcomeni A, Romiti GF, Romanazzi I, Raparelli V et al (2018) Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: a systematic review and meta-analysis of 993,600 patients. Int J Cardiol 269:182–191CrossRef

21.

Christenfeld NJ, Sloan RP, Carroll D, Greenland S (2004) Risk factors, confounding, and the illusion of statistical control. Psychosom Med 66:868–875CrossRef

22.

Renoux C, Coulombe J, Suissa S (2017) Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study. Eur Heart J 38:1473–1479PubMed

23.

Nielsen PB, Skjoth F, Overvad TF, Larsen TB, Lip GYH (2018) Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc? Circulation 137:832–840CrossRef

24.

Gerstein HC (2002) Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetes. Endocrinol Metab Clin N Am 31:537–551CrossRef

25.

Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ (1997) Coming to terms with the terms of risk. Arch Gen Psychiatry 54:337–343CrossRef

26.

Baron RM, Kenny DA (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173CrossRef

27.

Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D (2001) How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 158:848–856CrossRef

28.

Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257–354CrossRef

29.

Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429CrossRef

30.

Members ATF, Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747CrossRef

31.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRef

32.

Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS et al (2012) Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 8:125–136CrossRef

33.

Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D et al (2014) 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol 30:1114–1130CrossRef

34.

Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL et al (2016) 2016 focused update of the canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol 32:1170–1185CrossRef

35.

Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C et al (2018) 2018 focused update of the canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol 34:1371–1392CrossRef

36.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:e199–267PubMedPubMedCentral

37.

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 140:e125–e151CrossRef

38.

Chiang CE, Okumura K, Zhang S, Chao TF, Siu CW, Wei Lim T et al (2017) 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm 33:345–367CrossRef

39.

Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, Connell C et al (2018) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ 27:1209–1266CrossRef

40.

Joung B, Lee JM, Lee KH, Kim TH, Choi EK, Lim WH et al (2018) 2018 Korean guideline of atrial fibrillation management. Korean Circ J 48:1033–1080CrossRef

Title: Female sex and stroke in atrial fibrillation: an intriguing relationship
Authors: Giuseppe Boriani
Jacopo Colella
Jacopo Imberti
Elisa Fantecchi
Marco Vitolo
Publication date: 01-03-2020
Publisher: Springer International Publishing
Keywords: Stroke
Oral Anticoagulant
Atrial Fibrillation
Published in: Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-019-02169-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Defective spleen function in autoimmune gastrointestinal disorders

Handling shock in idiopathic systemic capillary leak syndrome (Clarkson’s disease): less is more—comment

Sex-related differences in prevalence, treatment and outcomes in patients with atrial fibrillation

High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde—comment

Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study

Liver alterations in anorexia nervosa are not caused by insulin resistance

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials